AR082277A1 - Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica - Google Patents

Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica

Info

Publication number
AR082277A1
AR082277A1 ARP110102319A ARP110102319A AR082277A1 AR 082277 A1 AR082277 A1 AR 082277A1 AR P110102319 A ARP110102319 A AR P110102319A AR P110102319 A ARP110102319 A AR P110102319A AR 082277 A1 AR082277 A1 AR 082277A1
Authority
AR
Argentina
Prior art keywords
antiadipogenic
activity
small molecules
composition
lipolitic
Prior art date
Application number
ARP110102319A
Other languages
English (en)
Inventor
Lijuan Zhang
Timothy J Falla
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of AR082277A1 publication Critical patent/AR082277A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Composición de moléculas pequeñas que tienen actividad lipolítica y antiadipogénica. Dos ejemplos de dichas moléculas son el ácido 4-metil-2-(octanoilamino)pentanoico y la N-isopentiloctanamida. Métodos para prevenir o tratar trastornos de la piel tales como la celulitis usando moléculas pequeñas que tienen actividad lipolítica y antiadipogénica.
ARP110102319A 2010-07-02 2011-06-30 Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica AR082277A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36117910P 2010-07-02 2010-07-02

Publications (1)

Publication Number Publication Date
AR082277A1 true AR082277A1 (es) 2012-11-28

Family

ID=44326260

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102319A AR082277A1 (es) 2010-07-02 2011-06-30 Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica

Country Status (22)

Country Link
US (1) US9511042B2 (es)
EP (1) EP2588101B1 (es)
JP (1) JP6043283B2 (es)
KR (1) KR101639196B1 (es)
CN (1) CN103079553B (es)
AR (1) AR082277A1 (es)
AU (1) AU2011271466B2 (es)
BR (1) BR112013000045A2 (es)
CA (1) CA2800301C (es)
DK (1) DK2588101T3 (es)
ES (1) ES2528012T3 (es)
HK (1) HK1179893A1 (es)
MX (1) MX362721B (es)
MY (1) MY156618A (es)
NZ (1) NZ605804A (es)
PL (1) PL2588101T3 (es)
RU (1) RU2590977C2 (es)
SG (1) SG186234A1 (es)
SI (1) SI2588101T1 (es)
TW (1) TWI539945B (es)
WO (1) WO2012003176A1 (es)
ZA (1) ZA201209603B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101935219B1 (ko) 2014-08-28 2019-01-03 칼리웨이 바이오파마슈티칼스 코., 엘티디. 국소 지방 및 체중 감소용 조성물 및 그의 제약 및 용도
US10226503B2 (en) 2014-08-28 2019-03-12 Caliway Biopharmaceuticals Co., Ltd. Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof
MX2018002462A (es) 2015-08-28 2018-06-19 Caliway Biopharmaceuticals Co Ltd Una composicion farmaceutica para reducir la grasa localizada y sus usos.
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
JP6972098B2 (ja) 2016-07-27 2021-11-24 ユニリーバー・ナームローゼ・ベンノートシヤープ 脂肪酸アミド誘導体を含むパーソナルケア組成物
US20200290950A1 (en) * 2017-10-05 2020-09-17 North Carolina State University Alkamide compounds and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85643A1 (fr) 1984-11-16 1986-06-04 Oreal Composition cosmetique thermo-amincissante a base d'extraits vegetaux oleosolubles
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
JP2701932B2 (ja) * 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
DK255889D0 (da) 1989-05-25 1989-05-25 Novo Nordisk As Fremgangsmaade til fremstilling af organiske forbindelser
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
JPH08337515A (ja) * 1995-04-11 1996-12-24 Kashima Sekiyu Kk 化粧料
FR2789085B1 (fr) * 1999-01-29 2003-06-20 Arkopharma Laboratoires Procede d'obtention d'une huile enrichie en acides gras hydroxyoctadecadienoiques (hode), ou de ses esters a partir d'un melange huileux contenant de l'acide linoleique, ou ses esters
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
CN1523982A (zh) 2001-03-27 2004-08-25 ���������Ǵ�ѧ���»� 减少体脂和调节脂肪酸代谢的方法、化合物和组合物
WO2003005836A2 (en) * 2001-07-10 2003-01-23 Trustees Of Boston University Modified-fat nutritional products useful for preventing or treating obesity
ITMI20030210A1 (it) 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
JP2005194252A (ja) * 2004-01-09 2005-07-21 Shiseido Co Ltd 脂肪蓄積抑制用組成物
WO2006029818A2 (en) * 2004-09-16 2006-03-23 Dsm Ip Assets B.V. Cosmetic compositions containing an hydroxamic acid compound optionally in combination with a retinoid
JP4527655B2 (ja) * 2004-11-30 2010-08-18 ライオン株式会社 フォーマー容器入り洗浄剤組成物
JP2008105945A (ja) 2005-02-07 2008-05-08 Ajinomoto Co Inc アディポネクチンの分泌促進又は誘導作用を有するアシルアミド化合物
JP2007153845A (ja) * 2005-12-07 2007-06-21 Yamaha Motor Co Ltd 脂肪蓄積抑制剤
JP5105297B2 (ja) * 2006-05-25 2012-12-26 味の素株式会社 Ｐｐａｒ活性調節剤
DE102006060439A1 (de) * 2006-12-19 2008-06-26 Henkel Kgaa Verbesserung der Hautverträglichkeit von hyperämisierenden Wirkstoffen
US20080200704A1 (en) 2007-02-20 2008-08-21 Multi Formulations Ltd. Preparation of amino acid-fatty acid amides

Also Published As

Publication number Publication date
US9511042B2 (en) 2016-12-06
CA2800301A1 (en) 2012-01-05
AU2011271466B2 (en) 2013-08-22
DK2588101T3 (en) 2015-02-02
EP2588101A1 (en) 2013-05-08
PL2588101T3 (pl) 2015-03-31
ZA201209603B (en) 2013-08-28
KR101639196B1 (ko) 2016-07-14
CN103079553A (zh) 2013-05-01
KR20130029432A (ko) 2013-03-22
SG186234A1 (en) 2013-01-30
TW201201794A (en) 2012-01-16
SI2588101T1 (sl) 2015-01-30
HK1179893A1 (en) 2013-10-11
EP2588101B1 (en) 2014-10-22
US20130096143A1 (en) 2013-04-18
RU2013104424A (ru) 2014-08-10
BR112013000045A2 (pt) 2016-05-10
MY156618A (en) 2016-03-15
JP2013530233A (ja) 2013-07-25
MX2012014751A (es) 2013-02-15
TWI539945B (zh) 2016-07-01
WO2012003176A1 (en) 2012-01-05
CN103079553B (zh) 2016-01-20
AU2011271466A1 (en) 2012-12-20
NZ605804A (en) 2014-03-28
MX362721B (es) 2015-02-27
JP6043283B2 (ja) 2016-12-14
ES2528012T3 (es) 2015-02-03
RU2590977C2 (ru) 2016-07-10
CA2800301C (en) 2018-03-27

Similar Documents

Publication Publication Date Title
CL2019001878A1 (es) Compuestos de microarn y métodos de modulación de la actividad de mir-21 (divisional solicitud 201402844).
BR112015011244A2 (pt) Análogos de compstatina de ação prolongada, método de fabricação e uso dos mesmos, bem como composição de qualidade farmacêutica
BR112013011730A2 (pt) composição de oligossacarídeos para tratar doenças da pele
CR20130410A (es) Compuestos y composiciones como inhibidores de la trk
BR112014019233A2 (pt) emplastros medicinais para criar ou manter uma área de tecido humano livre de contaminantes
CO6680663A2 (es) Composiciones pesticidas producidas de piranosas, composiciones que las contienen y su proceso de obtención
ECSP13012978A (es) Inhibidores de glucosilceramida sintasa
ITTO20110627A1 (it) Composizione farmaceutica di combinazione e metodi per trattare diabete e patologie metaboliche
AR082277A1 (es) Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica
BR112014027227A2 (pt) modificação alvejada de malato desidrogenase
CR20130267A (es) Inhibidores de nampt y rock
IN2013CN01340A (es)
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112012028648A2 (pt) uso cosmético de sulfoniloxibenzilaminas substituídas por n e compostos relacionados
BR112012024289A2 (pt) "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica"
BR112014010174A2 (pt) uso de uma composição para a fabricação de um produto para melhorar a função executiva de um indivíduo e para tratar o mesmo
BR112013022234A2 (pt) emulsão de dodecafluorpentano como uma terapia de acidente vascular cerebral e isquemia
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
UY32937A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
BR112012028719A2 (pt) composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
MX2015003701A (es) Composiciones para tratamiento.
BR112014012941A2 (pt) Composição para cuidado pessoal, método cosmético para tratar pele, e, métodos para inibir a degradação de colágeno na pele e para reduzir os sinais visíveis de envelhecimento
ES2661048T8 (es) Composición cosmética de líquido de eclosión de peces, métodos para su producción y usos de la misma para mejorar la apariencia cosmética de la piel
EP3337564A4 (en) COMPOSITION AND METHOD FOR THE USE OF TETRAHYDROISOCHINOLINE SMALL MOLECULES FOR THE BINDING AND MODULATION OF PCSK9 PROTEIN ACTIVITY

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure